about
Rationale, design and population baseline characteristics of the PERFORM vascular project: an ancillary study of the Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic stHDL-C, triglycerides and carotid IMT: a meta-analysis of 21,000 patients with automated edge detection IMT measurement.Clinical impact of intima media measurement.Mannheim intima-media thickness consensus.Stroke prevention, blood cholesterol and statins.Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006.Chlamydia pneumoniae seropositivity in aetiological subtypes of brain infarction and carotid atherosclerosis: a case control study.Assessment of subclinical atherosclerosis by carotid intima media thickness: technical issues.Intima-media thickness of carotid arteries.Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study.Spectrum of transient visual symptoms in a transient ischemic attack cohort.Carotid atherosclerosis and risk of subsequent coronary event in outpatients with atherothrombosis.Atherogenic dyslipidemia in patients with transient ischemic attack.Intracranial arterial dolichoectasia is associated with enlarged descending thoracic aorta.Aortic arch atheroma in transient ischemic attack patients.Circulating markers of endothelial dysfunction and platelet activation in patients with severe symptomatic cerebral small vessel disease.Coronary artery disease and risk of major vascular events after cerebral infarction.Matrix metalloproteinase-3 and intracranial arterial dolichoectasia.Blood lipids in brain infarction subtypes.Cerebral and extracerebral vasoreactivity in symptomatic lacunar stroke patients: a case-control study.Intracranial arterial dolichoectasia and small-vessel disease in stroke patients.Carotid intima media thickness and plaques can predict the occurrence of ischemic cerebrovascular events.Does ABCD2 score below 4 allow more time to evaluate patients with a transient ischemic attack?Cognitive impairment and carotid atherosclerosis in a general Italian midlife and old population.Clinical Significance of Isolated Atypical Transient Symptoms in a Cohort With Transient Ischemic Attack.Corrigendum to "HDL-C, triglycerides and carotid IMT: A meta-analysis of 21,000 patients with automated edge detection IMT measurement" [Atherosclerosis 232 (2014) 65-71].Overlap of Diseases Underlying Ischemic StrokePrevalence of Coronary Atherosclerosis in Patients With Cerebral InfarctionDetection and Management of Associated Atherothrombotic Locations in Patients with a Recent Atherothrombotic Ischemic Stroke: Results of the DETECT SurveyHormone replacement therapy use is associated with a lower occurrence of carotid atherosclerotic plaques but not with intima-media thickness progression among postmenopausal women. The vascular aging (EVA) studyIn vivo middle cerebral artery plaque imaging by high-resolution MRIDeterminants of carotid plaque occurrence. A long-term prospective population study: the San Daniele ProjectCarotid intima-media thickness, plaques, and Framingham risk score as independent determinants of stroke riskCarotid plaque morphology improves stroke risk prediction: usefulness of a new ultrasonographic scoreCountry-based reference values and impact of cardiovascular risk factors on carotid intima-media thickness in a French population: the 'Paroi Artérielle et Risque Cardio-Vasculaire' (PARC) StudyRestenosis is more frequent after carotid stenting than after endarterectomy: the EVA-3S studyCorrelation between the Framingham risk score and intima media thickness: the Paroi Artérielle et Risque Cardio-vasculaire (PARC) studyCerebral microemboli: smoking gun or innocent bystanders?Yield of systematic transcranial Doppler in patients with transient ischemic attackEffect of golimumab on carotid atherosclerotic disease measures and cardiovascular events in inflammatory arthritides
P50
Q33920331-2B92D989-A45A-47C0-84A3-13969DA18E5EQ34396468-591774C9-3D26-4205-A8D7-82CF4E31F12CQ35019536-6A63A750-A6A6-475F-8C38-1EFC1E565DBAQ35937841-5303CD38-CE4F-41EE-952E-4DB3F639DECEQ36298570-E8EDCCA4-83A5-4672-9007-0145A5855CC8Q36654798-174C53B9-CDE4-4FF5-ADE3-047D6B1CFB23Q37858958-DB1BD358-955E-4BF8-A154-8DF0F07488EFQ38026700-242C57CD-6835-473A-B109-F83FDDEB39DEQ38296996-0A7463C5-6FB8-40A3-9A43-0D9002750DA2Q43506227-B48A4B56-9099-4B82-9C75-5D1397BBE290Q43754725-4E1F6CCB-BBB2-4B87-B454-AF5082BD2FA8Q44733080-A0EBC067-9D58-4463-A341-884C4E827FA0Q44927220-D24A7AB6-1584-4C33-96EC-AD8CD07AF389Q45185808-457BE98F-079B-4B06-9DC5-E3C1989814CBQ45765757-C5D2BE2F-CEAF-4A5B-BEF1-721BA7B1A643Q46402915-894740B9-019F-47E9-82C7-85A451B702ADQ46730559-334B3872-A5A9-4CE6-905D-2753EC934955Q48215284-E9247EB1-9282-4C72-9ADD-83EE9D371ED5Q48548639-260882BB-2459-4295-9F0B-06A31C7666B8Q48659591-4DCABF41-36D6-47F4-B6D0-AAF39FE4D3D0Q48987500-982DCE40-E5A1-4ABB-8538-98B4378AC6CFQ49098182-82F8D580-C755-4D6F-A079-CD72CBB6FF70Q51825719-7AC8AAF8-F85A-47ED-96DD-D0B471F8CC50Q51981444-814D67CB-C006-41B2-ACD3-D8146DB543C9Q52095775-2589DFBF-3239-4AD7-B6CA-54EB5C618BB2Q52587466-A3FF1143-515C-4AEA-997E-12EFCC1512AEQ57243336-0F72EA26-3934-46CF-9CFB-6A4D1E1066D8Q57243386-6BCD5A4A-DAEC-4A7B-8050-0C78D54033F9Q57658451-A43F5259-7919-48B3-A4F4-C1321FA2D65CQ78663536-79E69029-9257-48AF-AC88-24327A2A492DQ79975931-2D148429-8D2D-4D23-A495-56F39DF181EFQ80123344-14BAA645-658A-4D7F-9EA5-712568DBDBAAQ80379010-30C9912B-12DB-4FAF-9E7F-098F4A9D9435Q83146079-BEB8C749-AFA1-46CB-86A4-D21A4812BFEBQ83355601-161052D6-E04C-4BAA-8F80-219904112913Q83395615-596E122E-B6D2-4168-B9B6-32A21AC8FD58Q83975575-37EB30A9-0FB1-428F-B4AF-75916C43B701Q84394102-1ABA51D4-0091-4781-AC1A-819C8F393AFBQ84487906-C75E5200-2B3D-4A45-8645-737DD2371125Q86982567-552436DB-1DEB-471D-B368-70E63EB37483
P50
description
Forscher
@de
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究員
@ja
研究者
@zh
name
Pierre-Jean Touboul
@en
Pierre-Jean Touboul
@nl
type
label
Pierre-Jean Touboul
@en
Pierre-Jean Touboul
@nl
prefLabel
Pierre-Jean Touboul
@en
Pierre-Jean Touboul
@nl
P106
P31
P496
0000-0002-8872-9917